Skip to main content
Log in

Synthesis in Escherichia coli and Characterization of Human Recombinant Erythropoietin with Additional Heparin-Binding Domain

  • Published:
Biochemistry (Moscow) Aims and scope Submit manuscript

Abstract

Recombinant human erythropoietin (EPO) with additional N-terminal heparin-binding protein domain (HBD) from bone morphogenetic protein 2 was synthesized in Escherichia coli cells. A procedure for HBD-EPO purification and refolding was developed for obtaining highly-purified HBD-EPO. The structure of recombinant HBD-EPO was close to that of the native EPO protein. HBD-EPO contained two disulfide bonds, as shown by MALDI-TOF mass spectrometry. The protein demonstrated in vitro biological activity in the proliferation of human erythroleukemia TF-1 cell test and in vivo activity in animal models. HBD-EPO increased the number of reticulocytes in the blood after subcutaneous injection and displayed local angiogenic activity after subcutaneous implantation of demineralized bone matrix (DBM) discs with immobilized HBD-EPO. We developed a quantitative sandwich ELISA method for measuring HBD-EPO concentration in solution using rabbit polyclonal serum and commercial monoclonal anti-EPO antibodies. Pharmacokinetic properties of HBD-EPO were typical for bacterially produced EPO. Under physiological conditions, HBD-EPO can reversibly bind to DBM, which is often used as an osteoplastic material for treatment of bone pathologies. The data on HBD-EPO binding to DBM and local angiogenic activity of this protein give hope for successful application of HBD-EPO immobilized on DBM in experiments on bone regeneration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

BCA:

2,2′-bicinchoninic acid

BMP-2:

bone morphogenetic protein 2

DBM:

demineralized bone matrix

DTT:

dithiothreitol

EPO:

erythropoietin

HBD:

heparinbinding domain

6His:

six-histidine tag

s-tag:

15-amino acid oligopeptide from bovine pancreas ribonuclease A

References

  1. Krantz, S. B. (1991) Erythropoietin, Blood, 77, 419–434.

    PubMed  CAS  Google Scholar 

  2. Shiozawa, Y., Jung, Y., Ziegler, A. M., Pedersen, E. A., Wang, J., Wang, Z., Song, J., Wang, J., Lee, C. H., Sud, S., Pienta, K. J., Krebsbach, P. H., and Taichman, R. S. (2010) Erythropoietin couples hematopoiesis with bone forma-tion, PLoS One, 5, e10853.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Wu, C., Giaccia, A. J., and Rankin, E. B. (2014) Osteoblasts: a novel source of erythropoietin, Curr. Osteoporos. Rep., 4, 428–432.

    Article  Google Scholar 

  4. Li, C., Shi, C., Kim, J., Chen, Y., Ni, S., Jiang, L., Zheng, C., Li, D., Hou, J., Taichman, R. S., and Sun, H. (2015) Erythropoietin promotes bone formation through EphrinB2/EphB4 signaling, J. Dent. Res., 94, 455–463.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Holstein, J. H., Menger, M. D., Scheuer, C., Meier, C., Culemann, U., Wirbel, R. J., Garcia, P., and Pohlemann, T. (2007) Erythropoietin (EPO): EPO-receptor signaling improves early endochondral ossification and mechanical strength in fracture healing, Life Sci., 80, 893–900.

    Article  PubMed  CAS  Google Scholar 

  6. Holstein, J. H., Orth, M., Scheuer, C., Tami, A., Becker, S. C., Garcia, P., Histing, T., Morsdorf, P., Klein, M., Pohlemann, T., and Menger, M. D. (2011) Erythropoietin stimulates bone formation, cell proliferation, and angio-genesis in a femoral segmental defect model in mice, Bone, 49, 1037–1045.

    Article  PubMed  CAS  Google Scholar 

  7. Garcia, P., Speidel, V., Scheuer, C., Laschke, M. W., Holstein, J. H., Histing, T., Pohlemann, T., and Menger, M. D. (2011) Low dose erythropoietin stimulates bone healing in mice, J. Orthop. Res., 29, 165–172.

    Article  PubMed  CAS  Google Scholar 

  8. Rolfing, J. H. D., Bendtsen, M., Jensen, J., Stiehler, M., Foldager, C. B., Hellfritzsch, M. B., and Bunger, C. (2012) Erythropoietin augments bone formation in a rabbit postero-lateral spinal fusion model, J. Orthop. Res., 30, 1083–1088.

    Article  PubMed  CAS  Google Scholar 

  9. Sun, H., Jung, Y., Shiozawa, Y., Taichman, R. S., and Krebsbach, P. H. (2012) Erythropoietin modulates the structure of bone morphogenetic protein 2-engineered cra-nial bone, Tissue Eng. Part A, 18, 2095–20105.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  10. Rolfing, J. H., Jensen, J., Jensen, J. N., Greve, A. S., Lysdahl, H., Chen, M., Rejnmark, L., and Bunger, C. (2014) A single topical dose of erythropoietin applied on a collagen carrier enhances calvarial bone healing in pigs, Acta Orthop., 85, 201–209.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Patel, J. J., Modes, J. E., Flanagan, C. L., and Krebsbach, P. H. (2015) Dual delivery of EPO and BMP2 from a novel modular poly-ε-caprolactone construct to increase the bone formation in prefabricated bone flaps, Tissue Eng. Part C Methods, 21, 889–897.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  12. Omlor, G. W., Kleinschmidt, K., Gantz, S., Speicher, A., Guehring, T., and Richter, W. (2016) Increased bone formation in a rabbit long-bone defect model after single local and single systemic application of erythropoietin, Acta Orthop., 87, 425–431.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Sinyukhin, V. N., Stetsyuk, E. A., and Lovchinsky, E. V. (1994) Pharmakinetics of human recombinant erythropoi-etin, Terapevt. Arkhiv, 66, 60–62.

    Google Scholar 

  14. Egrie, J. C., Strickland, T. W., Lane, J., Aoki, K., Cohen, A. M., Smalling, R., Trail, G., Lin, F. K., Browne, J. K., and Hines, D. K. (1986) Characterization and biological effects of recombinant human erythropoietin, Immunobiology, 172, 213–224.

    Article  PubMed  CAS  Google Scholar 

  15. Egrie, J. C., Dwyer, E., Browne, J. K., Hitz, A., and Lykos, M. A. (2003) Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin, Exp. Hematol., 31, 290–299.

    Article  PubMed  CAS  Google Scholar 

  16. Wang, Y. J., Liu, Y. D., Chen, J., Hao, S. J., Hu, T., Ma, G. H., and Su, Z. G. (2010) Efficient preparation and PEGylation of recombinant human non-glycosylated erythropoietin expressed as inclusion body in E. coli, Int. J. Pharm., 386, 156–164.

    Article  PubMed  CAS  Google Scholar 

  17. Jeong, T. H., Son, Y. J., Ryu, H. B., Koo, B. K., Jeong, S. M., Hoang, P., Do, B. H., Song, J. A., Chong, S. H., Robinson, R. C., and Choe, H. (2014) Soluble expression and partial purification of recombinant human erythropoi-etin from E. coli, Protein Expr. Purif., 95, 211–218.

    Article  PubMed  CAS  Google Scholar 

  18. Boissel, J. P., Lee, W. R., Presnell, S. R., Cohen, F. E., and Bunn, H. F. (1993) Erythropoietin structure–function rela-tionships. Mutant proteins that test a model of tertiary structure, J. Biol. Chem., 268, 5983–5993.

    Google Scholar 

  19. Narhi, L. O., Arakawa, T., Aoki, K., Wen, J., Elliott, S., Boone, T., and Cheetham, J. (2001) Asn to Lys mutations at three sites which are N-glycosylated in the mammalian protein decrease the aggregation of Escherichia coli-derived erythropoietin, Protein Eng., 14, 135–140.

    Article  PubMed  CAS  Google Scholar 

  20. Grunina, T. M., Demidenko, A. V., Lyaschuk, A. M., Poponova, M. S., Galushkina, Z. M., Soboleva, L. A., Cherepushkin, S. A., Polyakov, N. B., Grumov, D. A., Solovyev, A. I., Zhukhovitsky, V. G., Boksha, I. S., Subbotina, M. E., Gromov, A. V., Lunin, V. G., and Karyagina, A. S. (2017) Recombinant human erythropoi-etin with additional processable protein domains: purifica-tion of protein synthesized in Escherichia coli heterologous expression system, Biochemistry (Moscow), 82, 1285–1294.

    Article  CAS  Google Scholar 

  21. Karyagina, A. S., Boksha, I. S., Grunina, T. M., Demidenko, A. V., Poponova, M. S., Sergienko, O. V., Lyaschuk, A. M., Galushkina, Z. M., Soboleva, L. A., Osidak, E. O., Semikhin, A. S., Gromov, A. V., and Lunin, V. G. (2016) Optimization of rhBMP-2 active-form production in a heterologous expression system using microbiological and molecular genetic approaches, Mol. Genet. Microbiol. Virol., 31, 208–213.

    Article  Google Scholar 

  22. Bartov, M. S., Gromov, A. V., Poponova, M. S., Savina, D. M., Nikitin, K. E., Grunina, T. M., Manskikh, V. N., Gra, O. A., Lunin, V. G., Karyagina, A. S., and Gintsburg, A. L. (2016) Modern approaches to research of new osteogenic biomaterials on the model of regeneration of cranial critical-sized defects in rats, Bull. Exp. Biol. Med., 162, 273–276.

    Article  PubMed  CAS  Google Scholar 

  23. Shevchenko, A., Tomas, H., Havlis, J., Olsen, J. V., and Mann, M. (2006) In-gel digestion for mass spectrometric characterization of proteins and proteomes, Nat. Protoc., 1, 2856–2860.

    Article  PubMed  CAS  Google Scholar 

  24. Sharapova, N. E., Kotnova, A. P., Galushkina, Z. M., Lavrova, N. V., Poletaeva, N. N., Tukhvatulin, A. E., Semikhin, A. S., Gromov, A. V., Soboleva, L. A., Ershova, A. S., Zaitsev, V. V., Sergeenko, O. V., Lunin, V. G., and Karyagina, A. S. (2010) Production of the recombinant human bone morphogenetic protein-2 in Escherichia coli and testing of its biological activity in vitro and in vivo, Mol. Biol. (Moscow), 44, 1036–1044.

    Article  CAS  Google Scholar 

  25. Karyagina, A. S., Boksha, I. S., Grunina, T. M., Demidenko, A. V., Poponova, M. S., Sergienko, O. V., Lyashchuk, A. M., Galushkina, Z. M., Soboleva, L. A., Osidak, E. O., Bartov, M. S., Gromov, A. V., and Lunin, V. G. (2017) Two variants of recombinant human bone mor-phogenetic protein 2 (rhBMP-2) with additional protein domains: synthesis in an Escherichia coli heterologous expression system, Biochemistry (Moscow), 82, 613–624.

    Article  CAS  Google Scholar 

  26. Ramos, A. S., Schmidt, C. A., Andrade, S. S., Fronza, M., Rafferty, B., and Dalmora, S. L. (2003) Biological evaluation of recombinant human erythropoietin in pharmaceutical products, Braz. J. Med. Biol. Res., 36, 1561–1569.

    Article  PubMed  CAS  Google Scholar 

  27. Gromov, A. V., Nikitin, K. E., Karpova, T. A., Zaitsev, V. V., Sidirova, E. I., Andreeva, E. V., Bartov, M. S., Mishina, D. M., Subbotina, M. E., Shevelyagina, N. V., Sergienkov, M. A., Soboleva, L. A., Kotnova, A. P., Sharapova, N. E., Semikhin, A. S., Didenko, L. V., Karyagina, A. S., and Lunin, V. G. (2012) Development of a procedure for obtaining osteoplastic material based on demineralized bone matrix with the maximal content of native factor of bone tissue growth, Biotekhnologiya, 5, 66–75.

    Google Scholar 

  28. Osidak, E. O., Osidak, M. S., Sivogrivov, D. E., Portnaya, T. S., Grunina, T. M., Galushkina, Z. M., Lunin, V. G., Karyagina, A. S., and Domogatskii, S. P. (2014) Kinetics of BMP-2 release from collagen carrier: evaluation by enzyme immunoassay in the presence of plasma proteins, Bull. Exp. Biol. Med., 158, 104–108.

    Article  PubMed  CAS  Google Scholar 

  29. Heidenhain, M. (1905) Zeitschrift fur wissenschaftliche mikroskopie und fur mikroskopische technik, S. Hirzel-Leipzig, 22, 339.

    Google Scholar 

  30. Xing, G., Zhang, J., Chen, Y., and Zhao, Y. (2008) Identification of four novel types of in vitro protein modifications, J. Proteome Res., 7, 4603–4608.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  31. Biryukova, L. S., Ushakova, A. I., Kamshilova, N. I., Ose, I. V., Akimov, A. V., Skobeleva, T. F., and Badmaev, A. L. (2011) Estimation of safety and therapeutic efficacy of new preparation stimulating erythropoiesis (epoetin β) in patients subjected to programmed hemodialysis, Nefrol. Dializ, 13, 128–132.

    Google Scholar 

  32. Ruppert, R., Hoffmann, E., and Sebald, W. (1996) Human bone morphogenetic protein 2 contains a heparin-binding site, which modifies its biological activity, Eur. J. Biochem., 237, 295–302.

    Article  PubMed  CAS  Google Scholar 

  33. Vo, T. N., Kasper, F. K., and Mikos, A. G. (2012) Strategies for controlled delivery of growth factors and cells for bone regeneration, Adv. Drug Deliv. Rev., 64, 1292–1309.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  34. Zwingenberger, S., Langanke, R., Vater, C., Lee, G., Niederlohmann, E., Sensenschmidt, M., Jacobi, A., Bernhardt, R., Muders, M., Rammelt, S., Knaack, S., Gelinsky, M., Gunther, K. P., Goodman, S. B., and Stiehler, M. (2016) The effect of SDF-1α on low dose BMP-2 mediated bone regeneration by release from heparinized mineralized collagen type I matrix scaffolds in a murine critical size bone defect model, J. Biomed. Mater. Res. A, 104, 2126–2134.

    Article  PubMed  CAS  Google Scholar 

  35. Ribatti, D., Presta, M., Vacca, A., Ria, R., Giuliani, R., Dell’ Era, P., Nico, B., Roncali, L., and Dammacco, F. (1999) Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neo-vascularization in vivo, Blood, 93, 2627–2636.

    PubMed  CAS  Google Scholar 

  36. Kimakova, P., Solar, P., Solarova, Z., Komel, R., and Debeljak, N. (2017) Erythropoietin and its angiogenic activity, Int. J. Mol. Sci., 18, E1519.

    Article  PubMed  CAS  Google Scholar 

  37. Gaifullin, N. M., Karyagina, A. S., Gromov, A. V., Terpilovsky, A. A., Malanin, D. A., Demeshchenko, M. V., and Novochadov, V. V. (2016) Morphological properties of osteointegration upon using titanium implants with bioac-tive coating and recombinant bone morphogenetic protein rhBMP-2, Morfologiya, 149, 77–84.

    CAS  Google Scholar 

  38. Andreev, A. Yu., Zakharov, V. D., Zaratyants, O. V., Borzenok, S. A., Khubenova, M. Kh., Osidak, E. O., Krasheninnikov, S. V., Karyagina, A. S., and Domogatsky, S. P. (2016) Prospects in the administration of bone tissue growth factor in the content of collagen matrix for cornea strengthening (experimental study), Sovr. Tekhnol. Oftalmol., 4, 11–16.

    Google Scholar 

  39. Zakharov, V. D., Andreev, A. Yu., Zaratyants, O. V., Osidak, E. O., Borzenok, S. A., Krasheninnikov, S. V., Karyagina, A. S., and Domogatsky, S. P. (2016) Morphological changes in the rabbit cornea under the action of the bone and carti-lage tissue growth factor rhBMP-2 within the intracorneal collagen implant, Klin. Eksp. Morfol., 4, 36–42.

    Google Scholar 

  40. Zakharov, V. D., Zaratyants, O. V., Andreev, A. Yu., Osidak, E. O., Borzenok, S. A., Krasheninnikov, S. V., Karyagina, A. S., and Domogatsky, S. P. (2016) Effect of the growth factor rhBMP-2 in the content of collagen matrix on mor-phological and biomechanical properties of retina, Oftalmokhirurgiya, 4, 20–28.

    Google Scholar 

  41. Bartov, M. S., Gromov, A. V., Manskih, V. N., Makarova, E. B., Rubshtein, A. P., Poponova, M. S., Savina, D. M., Savin, K. S., Nikitin, K. E., Grunina, T. M., Boksha, I. S., Orlova, P. A., Krivozubov, M. S., Subbotina, M. E., Lunin, V. G., Karyagina, A. S., and Gintsburg, A. L. (2017) Recombinant human Bone Morphogenetic Protein-2 (rhBMP-2) with additional protein domain synthesized in E. coli: in vivo osteoinductivity in experimental models on small and large laboratory animals, Bull. Exp. Biol. Med., 164, 148–151.

    Article  PubMed  CAS  Google Scholar 

  42. Chen, X., Zaro, J. L., and Shen, W. C. (2013) Fusion protein linkers: property, design and functionality, Adv. Drug Deliv. Rev., 65, 1357–1369.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to A. S. Karyagina or A. V. Gromov.

Additional information

Original Russian Text © A. S. Karyagina, T. M. Grunina, M. S. Poponova, P. A. Orlova, V. N. Manskikh, A. V. Demidenko, N. V. Strukova, M. S. Manukhina, K. E. Nikitin, A. M. Lyaschuk, Z. M. Galushkina, S. A. Cherepushkin, N. B. Polyakov, A. I. Solovyev, V. G. Zhukhovitsky, D. A. Tretyak, I. S. Boksha, A. V. Gromov, V. G. Lunin, 2018, published in Biokhimiya, 2018, Vol. 83, No. 10, pp. 1504–1522.

Originally published in Biochemistry (Moscow) On-Line Papers in Press, as Manuscript BM18-141, August 13, 2018.

Electronic supplementary material

10541_2018_673_MOESM1_ESM.pdf

Supplement to: A. S. Karyagina, T. M. Grunina, M. S. Poponova, P. A. Orlova, V. N. Manskikh, A. V. Demidenko, N. V. Strukova, M. S. Manukhina, K. E. Nikitin, A. M. Lyaschuk, Z. M. Galushkina, S. A. Cherepushkin, N. B. Polyakov, A. I. Solovyev, V. G. Zhukhovitsky, D. A. Tretyak, I. S. Boksha, A. V. Gromov, and V. G. Lunin, Synthesis in Escherichia coli and Characterization of Human Recombinant Erythropoietin with Additional Heparin-Binding Domain (ISSN 0006-2979, Biochemistry (Moscow), 2018, Vol. 83, No. 10, pp. 1207-1221)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Karyagina, A.S., Grunina, T.M., Poponova, M.S. et al. Synthesis in Escherichia coli and Characterization of Human Recombinant Erythropoietin with Additional Heparin-Binding Domain. Biochemistry Moscow 83, 1207–1221 (2018). https://doi.org/10.1134/S0006297918100061

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S0006297918100061

Keywords

Navigation